These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 504550

  • 21. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
    Chobanian AV, Gavras H, Melby JC, Gavras I, Jick H.
    Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399
    [Abstract] [Full Text] [Related]

  • 22. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P, Fardella C, Oestreicher E, Gac H, Mosso L, Soto J, Foradori A, Claverie X, Ahuad J, Montero J.
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [Abstract] [Full Text] [Related]

  • 23. Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
    Halimi JM, Mimran A.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1801-2. PubMed ID: 8903655
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A, Mahgoub M, Hall M, Feely J.
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Biochemical correction in the syndrome of hypertension and hyperkalaemia by severe dietary salt restriction suggests renin-aldosterone suppression critical in pathophysiology.
    Klemm SA, Gordon RD, Tunny TJ, Finn WL.
    Clin Exp Pharmacol Physiol; 1990 Mar; 17(3):191-5. PubMed ID: 2187635
    [Abstract] [Full Text] [Related]

  • 29. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P.
    Schweiz Med Wochenschr; 1982 Dec 04; 112(49):1764-74. PubMed ID: 6758113
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible hereditary cell membrane defect.
    Farfel Z, Iaina A, Rosenthal T, Waks U, Shibolet S, Gafni J.
    Arch Intern Med; 1978 Dec 04; 138(12):1828-32. PubMed ID: 718348
    [Abstract] [Full Text] [Related]

  • 33. Type II pseudohypoaldosteronism. Report of a case and review of the literature.
    Muhammad S, Mamish ZM, Tucci JR.
    J Endocrinol Invest; 1994 Jun 04; 17(6):453-7. PubMed ID: 7930391
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Renin-aldosterone in elderly patients with hyperkalaemia under anaesthesia.
    Kudoh A, Sakai T, Ishihara H, Matsuki A.
    Eur J Anaesthesiol; 1999 Apr 04; 16(4):231-5. PubMed ID: 10234492
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.